Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMYCIN vs RIFAPENTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMYCIN vs RIFAPENTINE: Safety Overview

Metric RIFAMYCIN RIFAPENTINE
Total FAERS Reports 106 298
Deaths Reported 26 8
Death Rate 24.5% 2.7%
Hospitalizations 35 88
Average Patient Age 56.1 yrs 46.5 yrs
% Female Patients 54.5% 55.6%
FDA Approval Date Nov 16, 2018 Jun 22, 1998
Manufacturer N/A sanofi-aventis U.S. LLC
Route N/A ORAL
Marketing Status Discontinued Prescription